These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7585120)

  • 21. Deficiency of MAPK-activated protein kinase 2 (MK2) prevents adverse remodelling and promotes endothelial healing after arterial injury.
    Kapopara PR; von Felden J; Soehnlein O; Wang Y; Napp LC; Sonnenschein K; Wollert KC; Schieffer B; Gaestel M; Bauersachs J; Bavendiek U
    Thromb Haemost; 2014 Dec; 112(6):1264-76. PubMed ID: 25120198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dipyridamole directly inhibits vascular smooth muscle cell proliferation in vitro and in vivo: implications in the treatment of restenosis after angioplasty.
    Singh JP; Rothfuss KJ; Wiernicki TR; Lacefield WB; Kurtz WL; Brown RF; Brune KA; Bailey D; Dubé GP
    J Am Coll Cardiol; 1994 Mar; 23(3):665-71. PubMed ID: 8113550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carvedilol, a cardiovascular drug, prevents vascular smooth muscle cell proliferation, migration, and neointimal formation following vascular injury.
    Ohlstein EH; Douglas SA; Sung CP; Yue TL; Louden C; Arleth A; Poste G; Ruffolo RR; Feuerstein GZ
    Proc Natl Acad Sci U S A; 1993 Jul; 90(13):6189-93. PubMed ID: 8327499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blockade of vascular smooth muscle cell proliferation and intimal thickening after balloon injury by the sulfated oligosaccharide PI-88: phosphomannopentaose sulfate directly binds FGF-2, blocks cellular signaling, and inhibits proliferation.
    Francis DJ; Parish CR; McGarry M; Santiago FS; Lowe HC; Brown KJ; Bingley JA; Hayward IP; Cowden WB; Campbell JH; Campbell GR; Chesterman CN; Khachigian LM
    Circ Res; 2003 May; 92(8):e70-7. PubMed ID: 12690039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty.
    Chang MW; Barr E; Lu MM; Barton K; Leiden JM
    J Clin Invest; 1995 Nov; 96(5):2260-8. PubMed ID: 7593612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-24 Attenuates Neointimal Hyperplasia in the Diabetic Rat Carotid Artery Injury Model by Inhibiting Wnt4 Signaling Pathway.
    Yang J; Fan Z; Yang J; Ding J; Yang C; Chen L
    Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27231895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Influence of antisense N-ras 1 gene on smooth muscle cell proliferation after arterial injury].
    Zhou Y; Wang L; Zhou A
    Zhonghua Yi Xue Za Zhi; 1997 Mar; 77(3):220-3. PubMed ID: 9596965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenosine A₂B receptor agonism inhibits neointimal lesion development after arterial injury in apolipoprotein E-deficient mice.
    Bot I; de Vries H; Korporaal SJ; Foks AC; Bot M; van Veldhoven J; Ter Borg MN; van Santbrink PJ; van Berkel TJ; Kuiper J; Ijzerman AP
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2197-205. PubMed ID: 22743060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in perlecan expression during vascular injury: role in the inhibition of smooth muscle cell proliferation in the late lesion.
    Kinsella MG; Tran PK; Weiser-Evans MC; Reidy M; Majack RA; Wight TN
    Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):608-14. PubMed ID: 12615671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Celecoxib, a cyclooxygenase-2 inhibitor, reduces neointimal hyperplasia through inhibition of Akt signaling.
    Yang HM; Kim HS; Park KW; You HJ; Jeon SI; Youn SW; Kim SH; Oh BH; Lee MM; Park YB; Walsh K
    Circulation; 2004 Jul; 110(3):301-8. PubMed ID: 15238462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The ras-binding domain of ral GDS-like protein-2 as a ras inhibitor in smooth muscle cells.
    Fischer TH; Brittain J; Trabalzini L; Banes AJ; White GC; Smith CJ; Nichols TC
    Biochem Biophys Res Commun; 2003 Jun; 305(4):934-40. PubMed ID: 12767920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of neointimal smooth muscle cell accumulation in vivo by antisense cdc2 and cdk2 oligonucleotides in rat carotid artery.
    Abe J; Zhou W; Taguchi J; Takuwa N; Miki K; Okazaki H; Kurokawa K; Kumada M; Takuwa Y
    Biochem Biophys Res Commun; 1994 Jan; 198(1):16-24. PubMed ID: 8292019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin on smooth muscle cell proliferation in vitro and neointimal formation in vivo after vascular injury.
    Indolfi C; Cioppa A; Stabile E; Di Lorenzo E; Esposito G; Pisani A; Leccia A; Cavuto L; Stingone AM; Chieffo A; Capozzolo C; Chiariello M
    J Am Coll Cardiol; 2000 Jan; 35(1):214-21. PubMed ID: 10636283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A single amino acid change in Raf-1 inhibits Ras binding and alters Raf-1 function.
    Fabian JR; Vojtek AB; Cooper JA; Morrison DK
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5982-6. PubMed ID: 8016101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flavopiridol inhibits smooth muscle cell proliferation in vitro and neointimal formation In vivo after carotid injury in the rat.
    Ruef J; Meshel AS; Hu Z; Horaist C; Ballinger CA; Thompson LJ; Subbarao VD; Dumont JA; Patterson C
    Circulation; 1999 Aug; 100(6):659-65. PubMed ID: 10441105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin-(1-7) reduces smooth muscle growth after vascular injury.
    Strawn WB; Ferrario CM; Tallant EA
    Hypertension; 1999 Jan; 33(1 Pt 2):207-11. PubMed ID: 9931106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lercanidipine inhibits vascular smooth muscle cell proliferation and neointimal formation via reducing intracellular reactive oxygen species and inactivating Ras-ERK1/2 signaling.
    Wu JR; Liou SF; Lin SW; Chai CY; Dai ZK; Liang JC; Chen IJ; Yeh JL
    Pharmacol Res; 2009 Jan; 59(1):48-56. PubMed ID: 18973813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parathyroid-hormone-related protein as a regulator of pRb and the cell cycle in arterial smooth muscle.
    Fiaschi-Taesch N; Takane KK; Masters S; Lopez-Talavera JC; Stewart AF
    Circulation; 2004 Jul; 110(2):177-85. PubMed ID: 15210588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Smooth muscle cell proliferation is proportional to the degree of balloon injury in a rat model of angioplasty.
    Indolfi C; Esposito G; Di Lorenzo E; Rapacciuolo A; Feliciello A; Porcellini A; Avvedimento VE; Condorelli M; Chiariello M
    Circulation; 1995 Sep; 92(5):1230-5. PubMed ID: 7648670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Removal of heparan sulfate by heparinase treatment inhibits FGF-2-dependent smooth muscle cell proliferation in injured rat carotid arteries.
    Kinsella MG; Irvin C; Reidy MA; Wight TN
    Atherosclerosis; 2004 Jul; 175(1):51-7. PubMed ID: 15186946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.